NO331218B1 - Transdermalt befruktningshindrende avleveringssystem - Google Patents

Transdermalt befruktningshindrende avleveringssystem

Info

Publication number
NO331218B1
NO331218B1 NO20022420A NO20022420A NO331218B1 NO 331218 B1 NO331218 B1 NO 331218B1 NO 20022420 A NO20022420 A NO 20022420A NO 20022420 A NO20022420 A NO 20022420A NO 331218 B1 NO331218 B1 NO 331218B1
Authority
NO
Norway
Prior art keywords
fertilization
transdermal
delivery system
prevention
prevention delivery
Prior art date
Application number
NO20022420A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022420L (no
NO20022420D0 (no
Inventor
Te-Yen Chien
Original Assignee
Agile Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agile Therapeutics Inc filed Critical Agile Therapeutics Inc
Publication of NO20022420D0 publication Critical patent/NO20022420D0/no
Publication of NO20022420L publication Critical patent/NO20022420L/no
Publication of NO331218B1 publication Critical patent/NO331218B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20022420A 1999-11-24 2002-05-22 Transdermalt befruktningshindrende avleveringssystem NO331218B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16753599P 1999-11-24 1999-11-24
PCT/US2000/032043 WO2001037770A1 (en) 1999-11-24 2000-11-22 Improved transdermal contraceptive delivery system and process

Publications (3)

Publication Number Publication Date
NO20022420D0 NO20022420D0 (no) 2002-05-22
NO20022420L NO20022420L (no) 2002-07-18
NO331218B1 true NO331218B1 (no) 2011-11-07

Family

ID=22607771

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022420A NO331218B1 (no) 1999-11-24 2002-05-22 Transdermalt befruktningshindrende avleveringssystem

Country Status (21)

Country Link
EP (1) EP1242012B1 (zh)
JP (2) JP4841781B2 (zh)
KR (1) KR100758757B1 (zh)
CN (1) CN1399533A (zh)
AR (1) AR030037A1 (zh)
AT (1) ATE453374T1 (zh)
AU (2) AU784196B2 (zh)
BR (1) BR0015802B1 (zh)
CA (1) CA2391430C (zh)
CY (1) CY1110615T1 (zh)
DE (1) DE60043621D1 (zh)
DK (1) DK1242012T3 (zh)
ES (1) ES2338860T3 (zh)
IL (1) IL149655A0 (zh)
MX (1) MXPA02005224A (zh)
NO (1) NO331218B1 (zh)
NZ (1) NZ518723A (zh)
PT (1) PT1242012E (zh)
TW (1) TWI253350B (zh)
WO (1) WO2001037770A1 (zh)
ZA (1) ZA200203525B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US7045145B1 (en) 1999-11-24 2006-05-16 Agile Therapeutics, Inc. Transdermal contraceptive delivery system and process
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
EP1594483B1 (de) 2003-02-21 2006-07-19 Schering AG Uv-stabiles transdermales pflaster
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
RU2356580C2 (ru) * 2003-10-28 2009-05-27 Новен Фармасьютикалз, Инк Композиции и способы, обеспечивающие контролируемую потерю лекарственных средств и доставку в системах трансдермальной доставки лекарственных средств
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
UA89766C2 (en) 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
CN1313084C (zh) * 2004-11-05 2007-05-02 郑会义 一种透皮避孕药传送体系及制备方法
CN1318032C (zh) * 2005-01-24 2007-05-30 浙江大学 炔雌醇透皮吸收贴片
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
WO2008088593A2 (en) * 2006-09-27 2008-07-24 Surmodics, Inc. Additives and methods for enhancing active agent elution kinetics
GB0809905D0 (en) * 2008-06-02 2008-07-09 Secr Defence A Transdermal drug delivery device
CN102665683A (zh) 2009-10-12 2012-09-12 丽卡实验有限公司 紧急避孕药
JP5813093B2 (ja) * 2010-03-28 2015-11-17 エベストラ・インコーポレイテッドＥｖｅｓｔｒａ，Ｉｎｃ． 膣内薬物送達デバイス
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
IN2014DN03247A (zh) * 2011-11-04 2015-05-22 Agile Therapeutics Inc
ES2613721T3 (es) 2012-12-21 2017-05-25 Teikoku Pharma Usa, Inc. Composiciones y métodos para administración transdérmica de hormonas y otros agentes medicinales
AR094289A1 (es) * 2012-12-28 2015-07-22 Noven Pharma Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632740A (en) * 1968-06-13 1972-01-04 Johnson & Johnson Topical device for the therapeutic management of dermatological lesions with steroids
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
EP0721348B1 (en) * 1993-09-29 1999-09-01 Alza Corporation Monoglyceride/lactate ester permeation enhancer
ES2180658T3 (es) * 1994-11-17 2003-02-16 Toray Industries Preparado para absorcion percutanea.
CN1188189C (zh) * 1995-06-07 2005-02-09 奥瑟－麦内尔制药公司 基质层含有17－脱乙酰基诺孕酯的经皮贴片及基质的用途
US5762956A (en) * 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process

Also Published As

Publication number Publication date
NO20022420L (no) 2002-07-18
CY1110615T1 (el) 2015-04-29
NO20022420D0 (no) 2002-05-22
AR030037A1 (es) 2003-08-13
AU2006201918A1 (en) 2006-06-01
CN1399533A (zh) 2003-02-26
KR20020072280A (ko) 2002-09-14
JP2011231125A (ja) 2011-11-17
TWI253350B (en) 2006-04-21
NZ518723A (en) 2004-04-30
KR100758757B1 (ko) 2007-09-14
ES2338860T3 (es) 2010-05-13
IL149655A0 (en) 2002-11-10
MXPA02005224A (es) 2003-09-25
ZA200203525B (en) 2003-07-18
JP2003533434A (ja) 2003-11-11
AU784196B2 (en) 2006-02-23
DK1242012T3 (da) 2010-04-26
DE60043621D1 (de) 2010-02-11
AU1788301A (en) 2001-06-04
EP1242012A4 (en) 2006-05-31
EP1242012B1 (en) 2009-12-30
JP4841781B2 (ja) 2011-12-21
PT1242012E (pt) 2010-03-31
BR0015802A (pt) 2003-06-24
CA2391430C (en) 2009-10-06
ATE453374T1 (de) 2010-01-15
EP1242012A1 (en) 2002-09-25
WO2001037770A1 (en) 2001-05-31
CA2391430A1 (en) 2001-05-31
AU2006201918B2 (en) 2009-07-30
BR0015802B1 (pt) 2014-04-29

Similar Documents

Publication Publication Date Title
NO331218B1 (no) Transdermalt befruktningshindrende avleveringssystem
DE69832055D1 (de) Transdermales abgabesystem
DE60016271D1 (de) Medikamentenzuführvorrichtung
DE60037203D1 (de) Medikamentenspender
NO20004196L (no) Innretninger for legemiddelavlevering
NO20015193D0 (no) Betalingssystem
DE60020763D1 (de) Sterilisationssystem
DE50004430D1 (de) Fahrzeugelektrik-konfigurationssystem
DK1275397T3 (da) Lægemiddel til lokal anvendelse
IL137559A0 (en) Transdermal drug delivery system
DE60037935D1 (de) Kontinuierliches behandlungssystem
IS6163A (is) Lyfjakomplex
DE60001315D1 (de) Verteilervorrichtung
NO995609D0 (no) AGC-system
NO20022013L (no) Innretninger for transdermal legemiddellevering
DE60000781D1 (de) Transaktionssystem
SE9904290D0 (sv) Polypertide delivery system
NO991931D0 (no) System for tyverisikring
DK1183061T3 (da) Lægemiddelafgivelsessystem
NO995100A (no) Fôrspreder
IL150334A0 (en) Transdermal drug delivery system
FI990143A (fi) Maksujärjestelmä
DE60029669D1 (de) Anzeigesystem
NO995227D0 (no) Oppdriftsassistert forankringssystem
NO995041D0 (no) Frostsikringssystem

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees